Theratechnologies Q3 Sales $20.86M Miss $21.05M Estimate; Net Loss Of $746K Versus $7.5M A Year Ago
Portfolio Pulse from Benzinga Newsdesk
Theratechnologies (NASDAQ:THTX) reported Q3 sales of $20.86 million, missing the analyst consensus estimate of $21.05 million by 0.93 percent. However, this is a 0.21 percent increase over sales of $20.81 million the same period last year. The company also reported a net loss of $746K, which is significantly lower than the $7.5M loss a year ago.
September 26, 2023 | 11:54 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Theratechnologies missed Q3 sales estimates but showed a YoY increase and a significant reduction in net loss.
While Theratechnologies missed the sales estimate, the miss was by a small margin and there was a YoY increase in sales. Additionally, the significant reduction in net loss is a positive sign, indicating improved financial health. These mixed results make the short term impact on the stock price uncertain.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100